Skip to Main Content

Paper Details

Integrative Clinical and Genomic Characterization of MTAP-deficient Metastatic Urothelial Cancer.
Eur Urol Oncol
11
2023
Deficiency of MTAP, FGFR3, IMvigor210, MTAP, MTAP gene, MTAP-deficient Metastatic Urothelial Cancer, MTAPdef, MTAPdef tumors, MTAPhi, MTAPlo, MTAPprof, PATIENT, PI3KCA, RB1, TP53, chromosome 9p21, cisplatin, dysplasia-associated genes, mUC, metastatic cancer of the urinary tract, metastatic urothelial cancer, patients, platinum, platinum-refractory disease, tumor, tumors, urinary tract cancer
Author NameAffiliation
Jolanta BondarukThe University of Texas MD Anderson Cancer Center
Bogdan CzerniakThe University of Texas MD Anderson Cancer Center
Kenna R Mills ShawInstitute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center
Kenna R Mills ShawInstitute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center
Funda Meric-BernstamThe University of Texas MD Anderson Cancer Center
Pavlos MsaouelThe University of Texas MD Anderson Cancer Center
Linghua WangThe University of Texas MD Anderson Cancer Center
  • 1 - 7

Datasets

Release 1.2